Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0016020 | membrane | 2 | 5 |
Related structures:
AlphaFold database: E9AFH0
Term | Name | Level | Count |
---|---|---|---|
GO:0000302 | response to reactive oxygen species | 4 | 2 |
GO:0006950 | response to stress | 2 | 10 |
GO:0006979 | response to oxidative stress | 3 | 10 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009987 | cellular process | 1 | 10 |
GO:0033554 | cellular response to stress | 3 | 10 |
GO:0034599 | cellular response to oxidative stress | 4 | 10 |
GO:0042221 | response to chemical | 2 | 10 |
GO:0042743 | hydrogen peroxide metabolic process | 4 | 2 |
GO:0042744 | hydrogen peroxide catabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0050896 | response to stimulus | 1 | 10 |
GO:0051716 | cellular response to stimulus | 2 | 10 |
GO:0062197 | cellular response to chemical stress | 4 | 10 |
GO:0070887 | cellular response to chemical stimulus | 3 | 10 |
GO:0072593 | reactive oxygen species metabolic process | 3 | 2 |
GO:1901700 | response to oxygen-containing compound | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004601 | peroxidase activity | 2 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0016209 | antioxidant activity | 1 | 10 |
GO:0016491 | oxidoreductase activity | 2 | 10 |
GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor | 3 | 10 |
GO:0020037 | heme binding | 4 | 10 |
GO:0046906 | tetrapyrrole binding | 3 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0140825 | lactoperoxidase activity | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 239 | 243 | PF00656 | 0.525 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.349 |
CLV_NRD_NRD_1 | 197 | 199 | PF00675 | 0.630 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.546 |
CLV_PCSK_KEX2_1 | 104 | 106 | PF00082 | 0.331 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.333 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.621 |
CLV_PCSK_PC1ET2_1 | 104 | 106 | PF00082 | 0.348 |
CLV_PCSK_PC1ET2_1 | 146 | 148 | PF00082 | 0.454 |
CLV_PCSK_PC1ET2_1 | 246 | 248 | PF00082 | 0.705 |
CLV_PCSK_SKI1_1 | 104 | 108 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.207 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.553 |
DOC_ANK_TNKS_1 | 147 | 154 | PF00023 | 0.413 |
DOC_CYCLIN_yClb1_LxF_4 | 339 | 345 | PF00134 | 0.521 |
DOC_MAPK_gen_1 | 207 | 215 | PF00069 | 0.530 |
DOC_PP1_RVXF_1 | 123 | 130 | PF00149 | 0.328 |
DOC_PP4_FxxP_1 | 14 | 17 | PF00568 | 0.415 |
DOC_PP4_FxxP_1 | 159 | 162 | PF00568 | 0.340 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.642 |
DOC_USP7_MATH_1 | 346 | 350 | PF00917 | 0.497 |
DOC_USP7_MATH_2 | 311 | 317 | PF00917 | 0.501 |
DOC_USP7_UBL2_3 | 142 | 146 | PF12436 | 0.393 |
DOC_WW_Pin1_4 | 9 | 14 | PF00397 | 0.440 |
LIG_14-3-3_CanoR_1 | 109 | 115 | PF00244 | 0.440 |
LIG_14-3-3_CanoR_1 | 211 | 216 | PF00244 | 0.653 |
LIG_14-3-3_CanoR_1 | 247 | 253 | PF00244 | 0.735 |
LIG_14-3-3_CanoR_1 | 304 | 310 | PF00244 | 0.698 |
LIG_AP2alpha_2 | 217 | 219 | PF02296 | 0.572 |
LIG_APCC_ABBA_1 | 216 | 221 | PF00400 | 0.564 |
LIG_APCC_ABBAyCdc20_2 | 90 | 96 | PF00400 | 0.413 |
LIG_BIR_III_4 | 242 | 246 | PF00653 | 0.497 |
LIG_BRCT_BRCA1_1 | 176 | 180 | PF00533 | 0.434 |
LIG_deltaCOP1_diTrp_1 | 185 | 194 | PF00928 | 0.371 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.371 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.328 |
LIG_FHA_2 | 166 | 172 | PF00498 | 0.440 |
LIG_FHA_2 | 212 | 218 | PF00498 | 0.607 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.440 |
LIG_LIR_Apic_2 | 12 | 17 | PF02991 | 0.414 |
LIG_LIR_Apic_2 | 156 | 162 | PF02991 | 0.323 |
LIG_LIR_Apic_2 | 185 | 191 | PF02991 | 0.467 |
LIG_LIR_Gen_1 | 177 | 186 | PF02991 | 0.331 |
LIG_LIR_Gen_1 | 343 | 353 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 49 | 59 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 343 | 348 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.339 |
LIG_MLH1_MIPbox_1 | 176 | 180 | PF16413 | 0.440 |
LIG_Pex14_1 | 333 | 337 | PF04695 | 0.385 |
LIG_Pex14_2 | 47 | 51 | PF04695 | 0.440 |
LIG_SH2_CRK | 345 | 349 | PF00017 | 0.495 |
LIG_SH2_NCK_1 | 345 | 349 | PF00017 | 0.495 |
LIG_SH2_STAT3 | 224 | 227 | PF00017 | 0.670 |
LIG_SH2_STAT5 | 173 | 176 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.312 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.440 |
LIG_SH3_3 | 148 | 154 | PF00018 | 0.312 |
LIG_SH3_4 | 142 | 149 | PF00018 | 0.467 |
LIG_SUMO_SIM_anti_2 | 321 | 327 | PF11976 | 0.467 |
LIG_TRAF2_1 | 137 | 140 | PF00917 | 0.347 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.677 |
MOD_CK1_1 | 284 | 290 | PF00069 | 0.762 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.328 |
MOD_CK2_1 | 152 | 158 | PF00069 | 0.328 |
MOD_CK2_1 | 285 | 291 | PF00069 | 0.709 |
MOD_Cter_Amidation | 196 | 199 | PF01082 | 0.491 |
MOD_Cter_Amidation | 244 | 247 | PF01082 | 0.517 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.732 |
MOD_GlcNHglycan | 265 | 269 | PF01048 | 0.531 |
MOD_GlcNHglycan | 277 | 280 | PF01048 | 0.596 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.473 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.715 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.416 |
MOD_N-GLC_1 | 254 | 259 | PF02516 | 0.773 |
MOD_N-GLC_1 | 279 | 284 | PF02516 | 0.775 |
MOD_N-GLC_2 | 124 | 126 | PF02516 | 0.467 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.470 |
MOD_PIKK_1 | 223 | 229 | PF00454 | 0.692 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.459 |
MOD_PKA_2 | 237 | 243 | PF00069 | 0.609 |
MOD_PKB_1 | 209 | 217 | PF00069 | 0.569 |
MOD_Plk_1 | 220 | 226 | PF00069 | 0.670 |
MOD_Plk_4 | 211 | 217 | PF00069 | 0.655 |
MOD_ProDKin_1 | 9 | 15 | PF00069 | 0.435 |
MOD_SUMO_rev_2 | 139 | 143 | PF00179 | 0.347 |
TRG_DiLeu_BaEn_1 | 178 | 183 | PF01217 | 0.328 |
TRG_DiLeu_BaEn_3 | 26 | 32 | PF01217 | 0.438 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.328 |
TRG_ENDOCYTIC_2 | 345 | 348 | PF00928 | 0.380 |
TRG_ER_diArg_1 | 147 | 149 | PF00400 | 0.337 |
TRG_ER_diArg_1 | 229 | 232 | PF00400 | 0.540 |
TRG_ER_diArg_1 | 261 | 264 | PF00400 | 0.785 |
TRG_ER_diArg_1 | 70 | 73 | PF00400 | 0.350 |
TRG_NLS_MonoExtN_4 | 143 | 150 | PF00514 | 0.491 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.220 |
TRG_Pf-PMV_PEXEL_1 | 90 | 95 | PF00026 | 0.412 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCF6 | Leptomonas seymouri | 69% | 79% |
A0A1X0P5A0 | Trypanosomatidae | 49% | 80% |
A0A3Q8IJA1 | Leishmania donovani | 94% | 100% |
A0A422NR12 | Trypanosoma rangeli | 50% | 81% |
A4IBN6 | Leishmania infantum | 93% | 100% |
C9ZYZ5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 81% |
E9B6M5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
V5C2U7 | Trypanosoma cruzi | 51% | 81% |